131 related articles for article (PubMed ID: 1990565)
1. Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
Transplant Proc; 1991 Feb; 23(1 Pt 1):400-2. PubMed ID: 1990565
[No Abstract] [Full Text] [Related]
2. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
[TBL] [Abstract][Full Text] [Related]
3. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
[TBL] [Abstract][Full Text] [Related]
4. Impaired kidney graft survival in flow cytometric crossmatched positive donor-specific transfusion recipients.
Bou-Habib JC; Krams S; Colombe BW; Lou C; Bubar OT; Yousif B; Amend WJ; Salvatierra O; Melzer J; Garovoy MR
Transplant Proc; 1991 Feb; 23(1 Pt 1):403-4. PubMed ID: 1990566
[No Abstract] [Full Text] [Related]
5. Pretransplant flow cytometry crossmatch in first cadaveric kidney transplants.
Mascaretti L; Sioli V; Puglisi G; Rossini G; Trezzi D; Scarpino C; Scalamogna M; Sirchia G
Transplant Proc; 1995 Feb; 27(1):668-70. PubMed ID: 7879138
[No Abstract] [Full Text] [Related]
6. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric crossmatch for kidney transplantation.
Koktathong K; Vejbaesya S; Bejrachandra S; Pattanapanyasat K
J Med Assoc Thai; 2005 Jun; 88(6):769-74. PubMed ID: 16083217
[TBL] [Abstract][Full Text] [Related]
9. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
[TBL] [Abstract][Full Text] [Related]
10. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
11. The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation.
Thistlethwaite JR; Heffron TG; Stevens L; Buckingham M; Stuart JK; Stuart FP
Transplant Proc; 1990 Aug; 22(4):1897-8. PubMed ID: 2389478
[No Abstract] [Full Text] [Related]
12. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
13. Crossmatch tests--an analysis of UNOS data from 1991-2000.
Cho YW; Cecka JM
Clin Transpl; 2001; ():237-46. PubMed ID: 12211787
[TBL] [Abstract][Full Text] [Related]
14. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
[TBL] [Abstract][Full Text] [Related]
15. Renal transplantation in highly sensitized patients using the regional organ procurement crossmatch tray: the SEOPF kidney sharing system experience.
Tardif GN; McCalmon RT
Transplant Proc; 1993 Feb; 25(1 Pt 2):1571-3. PubMed ID: 8442195
[No Abstract] [Full Text] [Related]
16. Sex and age effects in renal transplantation.
Koka P; Cecka JM
Clin Transpl; 1990; ():437-46. PubMed ID: 2103166
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific flow cytometric cross-match after kidney transplantation.
Puig N; Pallardó LM; Villalba JV; Sánchez J; Crespo J; Rodriguez R; Montoro JA
Transplant Proc; 1995 Aug; 27(4):2369-70. PubMed ID: 7652842
[No Abstract] [Full Text] [Related]
18. The crossmatch may still be the most clinically relevant histocompatibility test performed.
Kerman R; Lappin J; Kahan B; Katz S; McKissick E; Hosek K; Acorda N; Wooley N; Hoover A; Miller K; Rodriguez L; Moore B; Melcher P; Biedermann B; Van Buren C
Clin Transpl; 2007; ():227-9. PubMed ID: 18642454
[TBL] [Abstract][Full Text] [Related]
19. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
[No Abstract] [Full Text] [Related]
20. Clinical transplants 1988. Overview.
Terasaki PI; Cecka JM; Takemoto S; Yuge J; Mickey MR; Park MS; Iwaki Y; Cicciarelli J; Cho Y
Clin Transpl; 1988; ():409-34. PubMed ID: 3154492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
